CD8A and cancer: The activated CD8+ T cells can induce specific destruction of cancer cells by releasing lytic components, it is the major killer of cancer cells in the anti-cancer immune response and constitutes the backbone of cancer immunotherapy (Raskov et al., 2021; Titu et al., 2002).